Active: new deal Jul 2026 Verified 6 Nov 2026
NEA
NEA is a VC firm based in Timonium, Maryland, United States that backs B2B software, Biotech and pharma, Fintech, Medtech and digital health.
- Type
- VC firm
- Location
- Timonium, Maryland, United States
- Stages
- Pre-seed, Seed, Series A, Series B, Growth
- Backs
- B2B software, Biotech and pharma, Fintech, Medtech and digital health
- Sectors
- AI, Healthtech and life sciences, Fintech, Biotech, Consumer
- Fund size / AUM
- $3.7B NEA 18 Venture Growth Equity (Form D offering, 2021)
- Latest fund or filing
- 18 Dec 2025
- Portfolio mix
- B2B software 23%; Biotech and pharma 22%; Fintech 17%; Medtech and digital health 15%; Hardware 8%; Consumer apps 7%; Deep tech 5%; Tech-enabled services 3% (n=28, 2012 to 2026)
- Website
- nea.com
Fund filings (SEC Form D)
- Latest fund on file
- New Enterprise Associates 19
- Filed
- 18 Dec 2025 (new notice)
- Fund size
- Not disclosed on the filing
- Fund vehicles filed in the last 12 months
- 3 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For NEA, the paid file holds: 8 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
Horizon3AiCloudflareFactoryDatabricksMongodb
Sources
- www.sec.gov/Archives/edgar/data/2079698/000207969825000001/
- nea.com/
- www.sec.gov/Archives/edgar/data/1880239/000101297522000253/
- nea.com/team
- nea.com/portfolio
- nea.com/about
Last checked 6 Nov 2026. Is something wrong? Tell us.
Appears in 98 lists
SaaS investors in Maryland (16)Series B consumer investors in the US (29)Series B biotech investors in the US (34)Series B medtech investors in the US (36)Venture capital firms in Maryland (39)Growth-stage biotech investors in the US (44)Series B medtech investors (57)Series B consumer investors (59)Series B fintech investors in the US (59)Series A biotech investors in the US (59)Growth-stage consumer investors in the US (60)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Series B biotech investors (73)Series A medtech investors in the US (76)Series A consumer investors in the US (80)Pre-seed biotech investors in the US (81)Pre-seed medtech investors in the US (95)Growth-stage fintech investors in the US (97)Pre-seed consumer investors in the US (104)Growth-stage medtech investors (107)Series B SaaS investors in the US (108)Growth-stage biotech investors (109)Growth-stage healthtech investors in the US (121)Growth-stage consumer investors (124)Series A medtech investors (125)Series B AI investors in the US (126)Series B fintech investors (127)Pre-seed medtech investors (129)Series A fintech investors in the US (145)Pre-seed biotech investors (148)Series A biotech investors (153)Series A consumer investors (154)Seed biotech investors in the US (159)Series B healthtech investors (160)Pre-seed consumer investors (162)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)Pre-seed fintech investors in the US (187)Series B SaaS investors (196)Series B AI investors (204)Seed medtech investors in the US (205)Growth-stage fintech investors (214)Seed consumer investors in the US (216)Pre-seed healthtech investors in the US (225)Series A SaaS investors in the US (256)Seed medtech investors (278)Series A AI investors in the US (280)Growth-stage investors in the US (288)Series A fintech investors (294)Growth-stage AI investors (295)Biotech venture capital firms in the US (297)Seed biotech investors (300)Growth-stage healthtech investors (316)Pre-seed fintech investors (323)Seed consumer investors (331)Series B investors (339)Growth-stage SaaS investors (344)Consumer venture capital firms in the US (348)Seed fintech investors in the US (349)Medtech venture capital firms in the US (350)Pre-seed SaaS investors in the US (367)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed AI investors in the US (403)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)Medtech investors (457)Series A SaaS investors (475)Biotech investors (484)Series A AI investors (500)Consumer investors (512)Fintech venture capital firms in the US (525)Pre-seed investors in the US (549)Pre-seed SaaS investors (562)Seed fintech investors (584)Pre-seed AI investors (633)Seed SaaS investors in the US (666)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Pre-seed investors (988)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)